Increasing number of research and development activities by key players in the market and robust pipeline of plant-based vaccines is expected to be a major factor driving the global plant-based vaccines market growth during the forecast period. For instance, in 2017, Medicago Inc.—a Canada-based biopharmaceutical company that focuses on development of plant-based vaccines—initiated phase 3 clinical trial to evaluate efficacy of its seasonal quadrivalent influenza vaccine (QIV) candidate. The trial comprises around 10,000 subjects in the following countries: the U.S., Canada, Germany, the U.K., the Philippines, Finland, and Thailand. QIV was developed using a new virus-like particle (VLP) technology, which is an alternative to egg-based and cell-based production systems.
Furthermore, in 2017, researchers from the Arizona State University (ASU), in the U.S., developed the first plant-based Zika vaccine. According to the university, the newly developed plant-based Zika vaccine is safer, potent, and its production cost is much cheaper. Such robust pipeline of plant-based vaccines is expected to be a major factor in growth of the global plant-based vaccines market during the forecast period.
Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/2004
Plant-Based Vaccines Market report presents the detail analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the Plant-Based Vaccines Market competitors.
Plant-Based Vaccines Market is a growing market into the following sector at present years. The Plant-Based Vaccines Market has uncovered rapid development in the current and past years and is probably going to proceed with a continuing development in the upcoming years.
Key Vendors of Plant-Based Vaccines Market: Key players operating in the global plant-based vaccines market include Medicago Inc., Mitsubishi Tanabe Pharma Corporation, iBio, Inc., Fraunhofer Center for Molecular Biotechnology (CMB), Protalix BioTherapeutics, and others.
Plant-Based Vaccines market report analyses the market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, and market demand and supply scenarios.
Request TOC of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/2004
Regions of Plant-Based Vaccines market:
Plant-Based Vaccines Market Taxonomy:
The global plant based vaccines market is segmented on the basis of vaccine type, application, and region By Vaccine Type- Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Others,. By Application- Influenza, Zika Virus, Ebola Virus, Others,. By Geography- North America, Latin America, Europe, Asia Pacific, Middle East, Africa,.
Moreover, various government initiatives for development of plant-based vaccines are also expected to fuel the plant-based vaccines market growth during the forecast period. For instance, in 2015, Public Health Agency of Canada (PHAC) granted a contract to Medicago Inc. for development of two plant-based vaccines for Sudan strain of Ebola virus.